Detection of TEM, SHV and per type extended-spectrum B-lactamase genes among clinical strains of pseudomonas aeruginosa isolated from burnt patients at Shafa-Hospital, Kerman, Iran

Iranian Journal of Basic Medical Sciences

Volumn 11, Issue 2, 2008, Pages 104-111

  Shakibaie, Mohammad Reza ^a   Shahcheraghi, Fereshteh ^b   Hashemi, Ali ^a   Saeed Adeli, N ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Antibiotic resistance; Esbl; MBL; Pseudomonas aeruginosa

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; BETA LACTAMASE PER; BETA LACTAMASE SHV; BETA LACTAMASE TEM; BETA LACTAMASE TEM 1; CEFOTAXIME; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGAR DIFFUSION; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BURN; BURN PATIENT; CHILD; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; YOUNG ADULT;

EID: 84860870779     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: 10.22038/IJBMS.2008.5220     Document Type: Article

References (22)

1. Aggarwal R, Chaudhary U, Bala K. Detection of extended-spectrum β-lactamase in Pseudomonas aeruginosa. Indian J Pathol Microbiol 2008; 51:222-224.
2. Nordmann P, Ronco E, Nass T. Characterzation of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1993; 37:962-769.
3. Tredget E E, Shankowsky HA, Rennie R. Pseudomonas infections in the thermally injured patients. Burns 2004; 30:3-26.
4. Moniri R, Mosayebi Z, Movehdian A. Emergence of multi-drug-resistant Pseudomonas aeruginosa isolates in neonatal septicemia. Infec Dis Antimicrob Agents 2005; 22:39-44.
5. Brasme L, Nordmann P, Fidel F. Incidence of class-A extended -spectrum β-lactamases in Champagne-Ardenne (France): a 1 year prospective study. Antimicrob Chemother 2007; 60:956-964.
6. Nathisuwan S, Burgess DS, Lewis JS II. Extended-spectrum A-lactamases: epidemiology, detection and treatment. Pharmaco 2001; 8:920-928.
7. Karmi Estahbanati H, Pour Kashani P, Ghanaatpisheh F. Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics. Burns 2002; 28: 340-348.
8. Gehard FW, Poirel L, Nordmann P. Ambler calss-A extended-spectrum A-lactamases in Pesudomonas aeruginosa: Novel development and clinical impact. Antimicrob Agents Chemother 2003; 47:2385-2392.
9. Vahaboglu H, Oeztuerk R, Ayguen G. Widespread detection of PER-1-type extended- spectrum A-lactamases among nosocomial acinetobacter and Pseudomonas aeruginosa isolates in Turkey: A nation wide multicenter study. Animicrob Agents Chemother 1997; 41:2265-2269.
10. Fluit A, Schmitz F. Class -I integron gene cassettes, mobility and epidemiology. Eur J Clincal Microbiol Infect Dis 1999; 18:761-770.
11. Poirel L, Rotimi V, Mokaddas E. VEB-1 like extended-spectrum β-lactamases in Pseudomonas aeruginosa, Kuwait. Emerg Infect Dis 2001; 7:486-470.
12. Lee S, Park Y, Kim M, Lee K. Prevalence of Ambler class -A and D β-lactamases among clinical isolates of Pseudomonas aerugnosa in Korea. Antimicrob Chemother 2005; 56:122-127.
13. Kim J, Lim Y, Rheem I. CTX-M and SHV-12 A-Lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Kelabsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol Letters 2005; 245:93-98.
14. Song W, Lee K M, Kang H J. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns 2001; 2:136-139.
15. Shahcheraghi F, Feizabadi M M, Yamin V, Abiri R. Serovar determination, drug resistance patterns and plasmid profiles of Pseudomonas aeruginosa isolated from burn patients at two hospitals of Tehran, Iran. Burns 2003;29:547-551
16. National Committee for Clinical Laboratory Standards (NCCLS): Performance of standards for antimicrobial disc susceptibility test-approved standard (document M2-A7) 7Th Ed. NCCLS, Pennsylvania, USA. (2000); ISBN 56-238208.
17. Norusis M Y. SPSS for windows: Base system user guide. Version 7.5- SPSS Inc., Chicago. 1993.
18. Mugnier P, Dubrous P, Casin I, Arlet G, et al. A TEM-derived extended spectrum β- lactamase in Pesudomonas aeruginosa. Antimirob Agents Chemother 1996; 40:2488-2493.
19. Song W, Lee KM, Kang HJ, et al. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns 2001; 2:136-139.
20. Khosravi A, Mihani F. Detection of Metallo-β-lactamase producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Diagnost Microbiol Infectious Disease 2008; 6:125-128.
21. Yamamano Y, Nishikawa T, Fujimura T, et al. OccVrance of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan. J Antibiot 2006; 59:791-796.
22. Jiang X, Zhang Z, Li M. Detection of extended-spectrum A-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006; 50:2990-2995.